secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeMD, Inc. (LFMD)
CIK:        0000948320
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001493152-25-023853
Event type: earnings
Sentiment:  positive
Materiality: 0.78
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeMD Q3 revenue $60.2M (+13%), adj EBITDA $5.1M; paid off debt, sold WorkSimpli
--------------------------------------------------------------------------------

- Total revenue $60.2M (+13% YoY); adjusted EBITDA $5.1M (+20% YoY).
- Telehealth revenue $47.3M (+18% YoY); telehealth adjusted EBITDA $2.9M (+30% YoY).
- Paid off all outstanding debt in Q3; divested majority stake in WorkSimpli after quarter end.
- Pennsylvania 503-A compounding pharmacy approved; licensed in 14 states, pursuing 50-state license.
- RexMD added nearly 10,000 net new subscribers; strong early traction in behavioral, women's, men's health.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/0001493152-25-023853-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-023853

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer